| Title |
Interventions for HIV‐associated nephropathy
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2013
|
| DOI | 10.1002/14651858.cd007183.pub3 |
| Pubmed ID | |
| Authors |
Ismail Yahaya, Olalekan A Uthman, Muhammed Mubashir B Uthman |
| Abstract |
Human immunodeficiency virus-associated nephropathy (HIVAN) is the most common cause of end stage kidney disease (ESKD) in human immunodeficiency virus-1 (HIV-1) serotype patients and it mostly affects patients of African descent. It rapidly progresses to ESKD if untreated. The goal of treatment is directed toward reducing HIV-1 replication and/or slowing the progression of chronic kidney disease. The following pharmacological agents have been used for the treatment of HIVAN: antiretroviral therapy, angiotensin-converting enzyme inhibitors (ACEi), steroids and recently cyclosporin. Despite this, the effect of each intervention is yet to be evaluated. |
Mendeley readers
The data shown below were compiled from readership statistics for 137 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 137 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 25 | 18% |
| Researcher | 12 | 9% |
| Student > Postgraduate | 11 | 8% |
| Student > Bachelor | 11 | 8% |
| Student > Ph. D. Student | 11 | 8% |
| Other | 18 | 13% |
| Unknown | 49 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 50 | 36% |
| Nursing and Health Professions | 11 | 8% |
| Biochemistry, Genetics and Molecular Biology | 3 | 2% |
| Immunology and Microbiology | 3 | 2% |
| Social Sciences | 3 | 2% |
| Other | 14 | 10% |
| Unknown | 53 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 March 2013.
All research outputs
#17,348,916
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#10,493
of 11,842 outputs
Outputs of similar age
#194,175
of 291,252 outputs
Outputs of similar age from Cochrane database of systematic reviews
#135
of 168 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 5th percentile – i.e., 5% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 291,252 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 168 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.